Endometrial cells in liquid-based cervical cytology: A diagnostic pitfall solved by preparing cytohistology from the residual thin layer sample

Acta Cytologica

Volumn 55, Issue 4, 2011, Pages 327-333

  Risse, E K J ^a   Ouwerkerk Noordam, E ^a   Boon, M E ^a  

^a LEIDEN CYTOLOGY AND PATHOLOGY LABORATORY   (Netherlands)

Author keywords

Cytohistology; Immunohistochemistry; Liquid based cervical cytology; Normal endometrium

Indexed keywords

KI 67 ANTIGEN; TUMOR MARKER;

ARTICLE; CLINICAL ARTICLE; COLPOSCOPY; ENDOMETRIUM CARCINOMA; ENDOMETRIUM CELL; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; PRIORITY JOURNAL; UTERINE CERVIX CYTOLOGY; ADENOCARCINOMA; CARCINOMA IN SITU; CYTODIAGNOSIS; CYTOLOGY; DIFFERENTIAL DIAGNOSIS; ENDOMETRIUM; ENDOMETRIUM TUMOR; ENZYME IMMUNOASSAY; METABOLISM; PATHOLOGY; PROGNOSIS; SQUAMOUS CELL CARCINOMA; STROMA CELL; UTERINE CERVIX TUMOR; VAGINA SMEAR;

ADENOCARCINOMA; CARCINOMA IN SITU; CARCINOMA, SQUAMOUS CELL; CYTODIAGNOSIS; CYTOLOGICAL TECHNIQUES; DIAGNOSIS, DIFFERENTIAL; ENDOMETRIAL NEOPLASMS; ENDOMETRIUM; FEMALE; HUMANS; IMMUNOENZYME TECHNIQUES; PROGNOSIS; STROMAL CELLS; TUMOR MARKERS, BIOLOGICAL; UTERINE CERVICAL NEOPLASMS; VAGINAL SMEARS;

EID: 80052899203     PISSN: 00015547     EISSN: 19382650     Source Type: Journal    
DOI: 10.1159/000327525     Document Type: Article

References (21)

1. Solomon D, Nayar R: The Bethesda System for Reporting Cervical Cytology, ed 2. New York, Springer Science and Business Media, 2004, p 58.
2. Risse EKJ, Ouwerkerk-Noordam E, Meijer- Marres EM, Boon ME: Exploiting the residual of cervical thin layer brush samples through cytohistology in cases with invasive carcinoma with application of antibodies. Acta Cytol 2010; 54: 175-182.
3. Boon ME, Ouwerkerk-Noordam E, Suurmeijer AJH, Kok LP: Diagnostic parameters in liquid-based cervical cytology using a coagulant suspension fixative. Acta Cytol 2005; 49: 513-519.
4. Liang J, Mittal KR, Wei JJ, Yee H, Chiriboga L, Shukla P: Utility of p16 INK4a , CEA, Ki-67, p53 and ER/PR in the differential diagnosis of benign, premalignant, and malignant glandular lesions of the uterine cervix and their relationship with Silverberg scoring system for endocervical glandular lesions. Int J Gynecol Pathol 2007; 26: 71-75.
5. Brown DC, Cole D, Gatter KC, Mason DY: Carcinoma of the cervix uteri: an assessment of tumour proliferation using the monoclonal antibody Ki-67. Br J Cancer 1988; 57: 178-181.
6. Garzetti GG, Ciavattini A, De Nictolis M, Lucarini G, Goteri G, Romanini C, Biagini G: MIB 1 immunostaining in cervical intraepithelial neoplasia: prognostic significance in mild and moderate lesions. Gynecol Obstet Invest 1996; 42: 261-266.
7. Lambert AP, Anschau F, Schmitt VM: p16 INK4a expression in cervical premalignant and malignant lesions. Exp Mol Pathol 2006; 80: 192-196.
8. O'Neill CJ, McCluggage WG: p16 INK4a expression in the female genital tract and its value in diagnosis. Adv Anat Pathol 2006; 13: 8-15.
9. Wentzensen N, Hampl M, Herkert M, Reichert A, Trunk MJ, Poremba C, Ridder R, von Knebel Doeberitz M: Identification of high-grade cervical dysplasia by the detection of p16 INK4a in cell lysates obtained from cervical samples. Cancer 2006; 107: 2307-2313.
10. Missaoui N, Hmissa S, Frappart L, Trabelsi A, Ben Abdelkader A, Traore C, Mokni M, Yaacoubi MT, Korbi S: p16 INK4a overexpression and HPV infection in uterine cervix adenocarcinoma. Virchows Arch 2006; 448: 597-603.
11. Yoshida T, Fukuda T, Sano T, Kanuma T, Owada N, Nakajima T: Usefulness of liquidbased cytology specimens for the immunocytochemical study of p16 expression and human papillomavirus testing: a comparative study using simultaneously sampled histology materials. Cancer 2004; 102: 100-108.
12. Zielinski GD, Snijders PJ, Rozendaal L, Daalmeijer NF, Risse EK, Voorhorst FJ, Jiwa NM, van der Linden HC, de Schipper FA, Runsink AP, Meijer CJ: The presence of highrisk HPV combined with specific p53 and p16 INK4a expression patterns points to highrisk HPV as the main causative agent for adenocarcinoma in situ and adenocarcinoma of the cervix. J Pathol 2003; 201: 535-543.
13. Barroeta JE, Pasha TL, Acs G, Zhang PJ: Immunoprofile of endocervical and endometrial stromal cells and its potential application in localization of tumor involvement. Int J Gynecol Pathol 2007; 26: 76-82.
14. McCluggage WG, Sumathi VP, Maxwell P: CD10 is a sensitive and diagnostically useful immunohistochemical marker of normal endometrial stroma and of endometrial stromal neoplasms. Histopathology 2001; 39: 273-278.
15. Shiozawa T, Nikaido T, Shimizu M, Zhai Y, Fujii S: Immunohistochemical analysis of the expression of CDK4 and p16 INK4 in human endometrioid-type endometrial carcinoma. Cancer 1997; 80: 2250-2256.
16. Nielsen GP, Stemmer-Rachamimov AO, Shaw J, Roy JE, Koh J, Louis DN: Immunohistochemical survey of p16 INK4A expression in normal human adult and infant tissues. Lab Invest 1999; 79: 1137-1143.
17. de Peralta-Venturino MN, Purslow MJ, Kini SR: Endometrial cells of the 'lower uterine segment' (LUS) in cervical smears obtained by endocervical brushings: a source of potential diagnostic pitfall. Diagn Cytopathol 1995; 12: 263-271.
18. Wilbur DC: Endocervical glandular atypia: a 'new' problem for the cytologist. Diagn Cytopathol 1995; 13: 463-469.
19. Heaton RB Jr, Harris TF, Larson DM, Henry MR: Glandular cells derived from direct sampling of the lower uterine segment in patients status post-cervical cone biopsy. A diagnostic dilemma. Am J Clin Pathol 1996; 106: 511-516.
20. Demay RM: Hyperchromatic crowded groups: pitfalls in Pap smear diagnosis. Am J Clin Pathol 2000; 114(suppl):S36-S43.
21. Lee KR, Genest DR, Minter LJ, Granter SR, Cibas ES: Adenocarcinoma in situ in cervical smears with a small cell (endometrioid) pattern: distinction from cells directly sampled from the upper endocervical canal or lower segment of the endometrium. Am J Clin Pathol 1998; 109: 738-742.